renal cell carcinoma peptides vaccine IMA901

{
  "id": "MLC-T-ONC-016491",
  "term": "renal cell carcinoma peptides vaccine IMA901",
  "field": "Oncology and biomedicine",
  "definition": "A multipeptide cancer vaccine targeting renal cell carcinoma with potential immunopotentiating activity. Renal cell carcinoma peptides vaccine IMA901 consists of 10 different synthetic tumor-associated peptide (TUMAP) antigens (9 HLA-class I-binding and 1 HLA class II-binding); endogenously, these TUMAPs are expressed by the majority of renal cell carcinomas. Vaccination with this agent may significantly increase host cytotoxic T-lymphocyte (CTL) immune responses against tumor cells expressing these peptide antigens.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/renal-cell-carcinoma-peptides-vaccine-ima901/"
}